Efficacy and safety of elbasvir/grazoprevir in treatment‐naive Chinese adults with hepatitis C virus infection: A randomized trial

Author:

Wei Lai1,Jia Ji Dong2,Duan Zhong Ping3,Wang Fu Sheng4,Niu Jun Qi5,Xie Wen6,Huang Wen Xiang7,Zhang Ming Xiang8,Huang Yan9,Wang Mao Rong10,Wu Shan Ming11,Zhao Ying Ren12,Jia Zhan Sheng13,Zhao Xu Min14,Mu Sheng Mei14,Liang Li Wen14,Wang Zaiqi14,Puenpatom Amy15,Hwang Peggy15,Robertson Michael N.15ORCID,Ingravallo Paul15,Asante‐Appiah Ernest15,Wei Bo15,Evans Barbara15,Hanna George J.15ORCID,Talwani Rohit15

Affiliation:

1. Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver Disease Peking University People's Hospital, Peking University Hepatology Institute Beijing China

2. Beijing Key Laboratory of Translational Medicine on Cirrhosis, National Clinical Research Center for Digestive Diseases Liver Research Center, Beijing Friendship Hospital, Capital Medical University Beijing China

3. Artificial Liver Center Beijing YouAn Hospital, Capital Medical University Beijing China

4. Treatment and Research Center for Infectious Diseases Beijing 302 Hospital Beijing China

5. Department of Hepatology First Hospital, Jilin University Changchun China

6. Center of Liver Diseases Beijing Ditan Hospital, Capital Medical University Beijing China

7. Division of Microbiology The First Affiliated Hospital of Chongqing Medical University Chongqing China

8. Department of Integrated Traditional and Western Medicine on Liver Diseases The Sixth People's Hospital of Shenyang Shenyang China

9. Department of Infectious Diseases Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University Changsha China

10. Center of Liver Disease The 81st Hospital of PLA Nanjing China

11. Department of Infectious Diseases Shanghai Public Health Center Shanghai China

12. Department of Infectious Disease First Affiliated Hospital of Medicine College, Xi'an Jiaotong University Xi'an China

13. Center of Infectious Diseases Tangdu Hospital, Fourth Military Medical University Xi'an China

14. Department of Infectious Diseases MSD China Beijing

15. Department of Infectious Diseases Merck & Co., Inc. Kenilworth New Jersey USA

Funder

Merck Sharp and Dohme

Publisher

Wiley

Subject

Gastroenterology,Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3